ARAY vs RCL · rev $401.9M vs P/E 26, rev $9.28B
Accuray Incorporated (ARAY) versus Royal Caribbean Cruises Ltd (RCL) — a side-by-side from cached financials, not a winner call.
Accuray Incorporated (ARAY) is a medical devices company listed on US.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Latest reported ARAY revenue for 2026-06-30 was $401.9M. Net income was -$49.2M. Revenue was down 12.3% from 2025-06-30 to 2026-06-30. ARAY currently screens at market cap $140.1M.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
ARAY currently screens at market cap $140.1M. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Not investment advice. Open the ARAY and RCL stock pages for the full models.
Not investment advice.